PERSISTENCE OF DE NOVO DONORSPECIFIC HLA-ANTIBODIES SEEMS TO INCREASE THE RISK OF LUNG ALLOGRAFT DYSFUNCTION

被引:0
|
作者
Schmitzer, Magdalena [1 ]
Winter, Hauke [1 ]
Kneidinger, Nikolaus [1 ]
Dick, Andrea [1 ]
Neurohr, Claus [1 ]
Kauke, Teresa [1 ]
机构
[1] Univ Clin, Munich, Germany
关键词
D O I
暂无
中图分类号
Q2 [细胞生物学];
学科分类号
071009 ; 090102 ;
摘要
P28
引用
收藏
页码:246 / 246
页数:1
相关论文
共 50 条
  • [31] EFFECT OF IMMUNE MONITORING OF DE NOVO HLA DONOR SPECIFIC ANTIBODIES (DNDSA) IN RENAL ALLOGRAFT RECIPIENTS
    Jain, Monika
    Bhargava, Vinant
    Gupta, Anurag
    Malik, Manish
    Gupta, Ashwani
    Bhalla, Anil K.
    Rana, Devinder S.
    Singh, Ravi Kumar
    HLA, 2020, 95 (04) : 311 - 311
  • [32] Anti-HLA DQ Antibodies Are Associated with Chronic Lung Allograft Dysfunction in a Pediatric Lung Transplant Population
    Si, X.
    Girnita, A. L.
    Lee, I.
    Vina, M. A. Fernandez
    Conrad, C. K.
    JOURNAL OF HEART AND LUNG TRANSPLANTATION, 2022, 41 (04) : S517 - S517
  • [33] Development of de novo HLA donor specific antibodies (HLA-DSA), HLA antibodies (HLA-Ab) and allograft rejection post blood transfusion in kidney transplant recipients
    Jalalonmuhali, M.
    Carroll, R. P.
    Tsiopelas, E.
    Clayton, P.
    Coates, P. T.
    HUMAN IMMUNOLOGY, 2020, 81 (07) : 323 - 329
  • [34] De novo production of anti-HLA donor specific antibodies during acute renal allograft rejection
    Crespo, M
    Pascual, M
    Tolkoff-Rubin, N
    Duan, JM
    Fitzpatrick, D
    Collins, AB
    Cosimi, AB
    Colvin, R
    Saidman, SL
    TRANSPLANTATION, 1999, 67 (07) : S87 - S87
  • [35] Donor-specific antibody characteristics, including persistence and complement-binding capacity, increase risk for chronic lung allograft dysfunction
    Iasella, Carlo J.
    Ensor, Christopher R.
    Marrari, Marilyn
    Mangiola, Massimo
    Xu, Qingyong
    Nolley, Eric
    Moore, Cody A.
    Morrell, Matthew R.
    Pilewski, Joseph M.
    Sanchez, Pablo G.
    McDyer, John F.
    Zeevi, Adriana
    JOURNAL OF HEART AND LUNG TRANSPLANTATION, 2020, 39 (12) : 1417 - 1425
  • [36] De novo donor-specific HLA antibodies in heart transplantation: Do transient de novo DSA confer the same risk as persistent de novo DSA?
    Moayedi, Yasbanoo
    Fan, Chun-Po S.
    Tinckam, Kathryn J.
    Ross, Heather J.
    McCaughan, Jennifer A.
    CLINICAL TRANSPLANTATION, 2018, 32 (11)
  • [37] Phosphorylated S6 ribosomal protein expression by immunohistochemistry correlates with de novo donor-specific HLA antibodies in lung allograft recipients
    Cone, Brian D.
    Zhang, Jennifer Q.
    Sosa, Rebecca A.
    Calabrese, Fiorella
    Reed, Elaine F.
    Fishbein, Gregory A.
    JOURNAL OF HEART AND LUNG TRANSPLANTATION, 2021, 40 (10) : 1164 - 1171
  • [38] Intragraft donor-specific anti-HLA antibodies in phenotypes of chronic lung allograft dysfunction
    Sacreas, Annelore
    Taupin, Jean-Luc
    Emonds, Marie-Paule
    Daniels, Liesbeth
    Van Raemdonck, Dirk E.
    Vos, Robin
    Verleden, Geert M.
    Vanaudenaerde, Bart M.
    Roux, Antoine
    Verleden, Stijn E.
    De Leyn, P.
    Nafteux, P.
    Decaluwe, H.
    Van Veer, H.
    Ceulemans, L. J.
    Depypere, L.
    Van Herck, Anke
    Kaes, Janne
    Heigl, Tobias
    Ordies, Sofie
    De Sadeleer, Laurens J.
    Vanstapel, Arno
    Neyrinck, Arne P.
    Schaevers, Veronique
    Dupont, Lieven J.
    Yserbyt, Jonas
    Godinas, Laurent
    Van Veer, Coosemans Hans
    Nafteux, Philippe
    Decaluwe, Herbert
    EUROPEAN RESPIRATORY JOURNAL, 2019, 54 (05)
  • [39] IGM- AND IGG-ANTIBODIES AGAINST HLA ARE ASSOCIATED WITH CHRONIC LUNG ALLOGRAFT DYSFUNCTION AFTER LUNG TRANSPLANTATION
    Kauke, T.
    Kneidinger, N.
    Dick, A.
    Schramm, R.
    Behr, J.
    Hatz, R.
    Neurohr, C.
    Winter, H.
    TRANSPLANT INTERNATIONAL, 2014, 27 : 49 - 49
  • [40] Stimulation Of De Novo Donor Specific Antibodies And Early Allograft Function Following Human Lung Transplantation
    Nunley, D. R.
    Bauldoff, G. S.
    Szalacha, L. A.
    Steele, M.
    Luger, A.
    Ramirez, A.
    Van Berkle, V.
    AMERICAN JOURNAL OF RESPIRATORY AND CRITICAL CARE MEDICINE, 2015, 191